当前位置：
X-MOL 学术
›
Cancer Cell
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer
Cancer Cell ( IF 48.8 ) Pub Date : 2024-08-12 , DOI: 10.1016/j.ccell.2024.07.009 Xiaoju Wang , Yuanyuan Qiao , Irfan A. Asangani , Bushra Ateeq , Anton Poliakov , Marcin Cieślik , Sethuramasundaram Pitchiaya , Balabhadrapatruni V.S.K. Chakravarthi , Xuhong Cao , Xiaojun Jing , Cynthia X. Wang , Ingrid J. Apel , Rui Wang , Jean Ching-Yi Tien , Kristin M. Juckette , Wei Yan , Hui Jiang , Shaomeng Wang , Sooryanarayana Varambally , Arul M. Chinnaiyan
Cancer Cell ( IF 48.8 ) Pub Date : 2024-08-12 , DOI: 10.1016/j.ccell.2024.07.009 Xiaoju Wang , Yuanyuan Qiao , Irfan A. Asangani , Bushra Ateeq , Anton Poliakov , Marcin Cieślik , Sethuramasundaram Pitchiaya , Balabhadrapatruni V.S.K. Chakravarthi , Xuhong Cao , Xiaojun Jing , Cynthia X. Wang , Ingrid J. Apel , Rui Wang , Jean Ching-Yi Tien , Kristin M. Juckette , Wei Yan , Hui Jiang , Shaomeng Wang , Sooryanarayana Varambally , Arul M. Chinnaiyan
No Abstract
中文翻译：
前列腺癌ERG基因融合产物的拟肽抑制剂的开发
无摘要
更新日期：2024-08-12
中文翻译：
前列腺癌ERG基因融合产物的拟肽抑制剂的开发
无摘要
京公网安备 11010802027423号